The Guilty Gilt Guide was written with a clear objective – to maximize the whole-herd performance of pig populations by helping gilts to reach their full reproductive potential and produce healthy pigs that reach their full genetic potential during grow-finish.
The open reading frames (ORF)5 represents approximately 4% of the porcine repro- ductive and respiratory syndrome virus (PRRSV)-2 genome (whole-PRRSV) and is often determined by the Sanger technique, which rarely detects >1 PRRSV strain if present in the sample.
Porcine reproductive and respiratory syndrome virus (PRRSV) is an important swine pathogen affecting the global swine industry.
Mycoplasma hyopneumoniae (M. hyopneumoniae) infections continue to result in significant respiratory challenges in the swine industry worldwide. Vaccination for M. hyopneumoniae is commonly utilized, as reduction in bacterial loads and clinical severity in vaccinated pigs have been shown. However, the effect of M. hyopneumoniae vaccination on transmission across different pig populations has been minimally investigated.
Don’t miss any news on PRRS disease control Subscribe now to PRRS.com newsletter
PRRS MLV vaccination is an important part of the solution when PRRS is involved in a PRDC problem. A strategy of PRRSV MLV vaccination at 3-4 weeks before PRRSV infection is a promising method for providing sufficient immunity to pigs against PRRSV
Efficacy of Type 2 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against the 2010 isolate of Vietnamese highly pathogenic PRRSV challenge in pigs
The key of succession of PRRS vaccination is that confirming by monitoring that there is no vertical/horizontal transmission of PRRS virus before weaning and when the field exposure of PRRS virus was occurred
After the implementation of Ingelvac® PRRS MLV piglet vaccination, PRRS stabilization was achieved and an overall improvement in productivity was observed.